1h Free Analyst Time
The global transport media market was valued at USD 13.15 billion in 2022 and is expected to reach USD 12.59 billion by 2028 Speak directly to the analyst to clarify any post sales queries you may have.
MARKET DRIVERS & OPPORTUNITIES
Technological Advancement in Transport Media
During the COVID-19 pandemic, several advancements and new products have been launched in the transport media market. For several decades several transport media solutions have been introduced in the market to stabilize the specimen for the detection of microbial presence during the diagnostic investigation. From 2019 to 2022, some of the new products launched by various vendors were based on the high demand for diagnosing SARS-COV-2 viral infection. In addition, the development of formulations and advanced designs for appropriate sample collection increased the adoption of transport media and delivered lucrative market growth opportunities. In addition, the emerging monkeypox infectious disease is expected to drive the transport media market.Several infectious disease outbreaks have significantly improved transport media solutions in recent years. Several new products are introduced with advanced and unique technologies to ease in detection and diagnosis of infected patients. Thermo Fisher Scientific designed a fully innovative non-hazardous virus inactivation medium that supports the safe collection and transport of the COVID-19 virus. In 2021, VIRCELL S.L. launched a new transport medium solution for pediatric clinical diagnostics for collecting and preserving various viruses. In addition, the increased funding for infectious diseases diagnosis and growing research towards viral transport media due to the COVID-19 pandemic deliver lucrative opportunities for transport media market growth.
Impact of COVID-19
The COVID-19 pandemic positively increased awareness about diagnosis and transport media relations among medical professionals and people, which drove the high demand for transport media. Also, the increasing production capacity of transport media solutions increases the high capacity of manufacturers. Most leading and emerging market players expand their manufacturing units with advanced facilities, expected to drive transport media market growth.Increasing Prevalence of Infectious Diseases
In 2019, the viral infection SARS-COV-2 started to spread worldwide, and millions of people got infected as of November 2022. With the increasing prevalence of infectious diseases worldwide, the demand for transport media increased in detecting and diagnosing viral and non-viral infectious diseases. The emerging and re-emerging infectious diseases impacting human life cause millions of deaths annually. The growing burden of infectious diseases continuously increases the demand for transport media solutions and boosts market growth. The increasing diagnosis rate for infectious diseases is accelerating the transport media industry's growth. Globally, billions of lives are attributed to infectious diseases. The increasing awareness, rising healthcare expenditure, and growing access to health services resulted in the high demand for infectious disease cures, propelling the market growth.SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT
The global transport media market by product is segmented into viral transport media, universal transport media, molecular transport media, and others. The other transport media segments included Cary & Blair medium, Amies medium, Stuarts medium, alkaline peptone water, and buffered glycerol saline. In 2022, the viral transport media segment accounted for a 55.75% higher industry share and dominated the other segments. The factors that increase the high revenue of viral transport media are the significant patient population infected with viral infectious diseases, significant diagnosis and testing done for COVID-19, and increasing awareness for diagnosis and pre-clinical diagnosis and testing. These factors significantly improved the viral transport media application rate and accelerated segmental growth. In the UK, the government has published and implemented guidelines to test monkeypox specimen samples and sample transporting through viral transport media.Segmentation by Product
- Viral Transport Media
- Universal Transport Media
- Molecular Transport Media
INSIGHTS BY APPLICATION
The global transport media market by application is segmented into diagnosis and pre-clinical testing. The diagnosis segment accounted for a 65.75% higher market share in 2022 and dominated the application segment. Due to the increasing infectious diseases prevalence and the emergence of COVID-19, monkeypox, and influenza virus infection in developed and developing countries, the demand for diagnosis is increased, which resulted in high segmental growth. In developed regions such as North America and Europe, the pre-clinical testing rate is higher than in developing regions such as APAC, Latin America, & Middle East & Africa. North America and Europe are showing steady growth for pre-clinical testing and driving segmental growth.Segmentation by Application
- Diagnosis
- Pre-clinical Testing
INSIGHTS BY INDICATION
The viral diseases indication segment dominated the global transport media in 2022 and was valued at USD 9.74 million. The prevalence of viral infectious diseases such as influenza virus, herpes simplex virus, varicella zoster, respiratory syncytial virus, and other emerging such as monkeypox and already emerged COVID-19 infectious diseases drive high segmental growth. Moreover, COVID-19 and influenza are both contagious respiratory illnesses caused by different types of viruses, such as COVID-19 is caused by SARS-COV-2, and the influenza virus causes flu. Influenza and COVID-19 are considered severe public health concerns worldwide, impacting millions of lives. Since 2020, across the world, various public health and social measures have been implemented to mitigate the COVID-19 pandemic caused by SARS-COV-2. In 2022, the viral diseases segment accounted for a 74.05% market share in the global transport media market.Segmentation by Indication
- Viral Diseases
- Non-Viral Diseases
INSIGHTS BY END-USER
The diagnostics labs became a major health service from 2020 to 2022 due to COVID-19 and other infectious disease detection. Due to the increased demand for diagnosis and testing in the COVID-19 pandemic, diagnostic labs have become a major part of diagnosis and accounted for a higher transport media market share in 2022. The high number of COVID-19 detection tests and emerging demand for monkeypox and influenza virus burden in 2022 are accelerating the segmental growth. In addition, other infectious diseases constantly demanded early detection and diagnosis to boost segmental growth. However, the diagnostic lab's segment growth is expected to decrease with the decreasing demand for COVID-19 diagnosis. And the hospitals and clinics segment is expected to increase with a substantial growth rate during the forecast period. In 2022, the diagnostic lab segment accounted for 41.52% market share in the global transport media market.Segmentation by End-users
- Diagnostic Labs
- Hospitals & Clinics
- Others
GEOGRAPHICAL ANALYSIS
North America dominated the transport media market and accounted for a 33.02% share in 2022. The increasing prevalence of viral infectious diseases and associated population, high diagnostic and pre-clinical testing rate, and increasing focus on research and development in the region on viral diseases boost the regional industry growth. The region's higher prevalence of infectious diseases continuously accelerates the diagnosis and testing demand, leading to an increased high requirement for transport media solutions. North America was one of the major regions affected by the SARS-COV-2 infection and delivered higher market growth by transport media solutions.Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- Italy
- France
- Spain
- Germany
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
VENDOR LANDSCAPE
The leading global transport media market players include BD, Puritan Medical, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Hardy Diagnostics, HiMedia Laboratories, and Vircell. The global industry is highly competitive, with local, domestic, regional, and global players worldwide. The market player's geographical presence and broad distribution channels make the market competitive through major supply, import, and export strategies. During the COVID-19 pandemic, the significantly increased demand for transport media drove high export and import in different countries through various market players.Key Company Profiles
- BD
- Hardy Diagnostics
- HiMedia Laboratories
- Laboratory Corporation of America
- Puritan Medica Products
- Thermo Fisher Scientific
- Vircell
Other Prominent Vendors
- AB Medical
- Alpha-Tec Systems
- AccuGene USA
- Apical Scientific
- Azooka Labs
- Biomed Diagnostics
- bioBoaVista
- BioGenex
- BIOLOGIX Group
- BIOCOMMA
- Charm Sciences
- Creative Life Sciences
- Citotest Labware Manufacturing
- CPT Medical
- COPAN Diagnostics
- DiaSorin Molecular
- EKF Diagnostics Holding
- Ensol Biosciences
- General Biologics
- Gentueri
- Han Chang Medic
- Hebei Chaoran Medical Instruments
- Innolyzer Labs
- KSL Diagnostics
- Lucence Health
- LaunchWorks
- Liofilchem
- Medical Wire & Equipment
- Miraclean Technology
- MetaDesign Solutions
- Quidel Corporation
- Trinity Biotech
- Manila HealthTek
- MATTEK
- Nodford International
- Starplex Scientific
- Sansure Biotech
- Sisco Research Laboratories
- Teknova
- Titan Biotech
- Vegas Biotech
- Yocon Biology Technology Company
- Zybio
KEY QUESTIONS ANSWERED
1. How big is the transport media market?2. What is the projected CAGR of the transport media market during the forecast period?
3. Who are the key players in the global transport media market?
4. What are the growing trends in the transport media market?
5. Which region holds the most significant global transport media market share?
Table of Contents
1 Research Methodology2 Research Objectives
3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market by Product Segment
4.3.2 Market by Application Segment
4.3.3 Market by Indication Segment
4.3.4 Market by End-Users
4.3.5 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Premium Insights
6.1 Overview
7 Market at a Glance
8 Introduction
8.1 Overview
9 Market Opportunities & Trends
9.1 New Product Launched for Transport Media
9.2 Technological Advances in Transport Media
9.3 Rapid Acceleration of Diagnostics and Funding During Pandemic
9.4 Increasing Research and Focus on Viral Transport Media
10 Market Growth Enablers
10.1 Impacts of Covid-19
10.2 Increasing Prevalence of Infectious Diseases
10.3 Increasing Diagnosis Rate for Infectious Diseases
11 Market Restraints
11.1 Available Alternative Solutions for Transport Media
11.2 Limited Access to Diagnostic Services in Lmics
11.3 Challenges Associated With Transport Media
12 Market Landscape
12.1 Market Overview
12.2 Market Size & Forecast
12.2.1 Insights by Product
12.2.2 Insights by Application
12.2.3 Insights by Indication
12.2.4 Insights by End-Users
12.2.5 Insights by Geography
12.3 Five Forces Analysis
12.3.1 Threat of New Entrants
12.3.2 Bargaining Power of Suppliers
12.3.3 Bargaining Power of Buyers
12.3.4 Threat of Substitutes
12.3.5 Competitive Rivalry
13 Product
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Viral Transport Media (Vtm)
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Market by Geography
13.4 Universal Transport Media (Utm)
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Market by Geography
13.5 Molecular Transport Media (Mtm)
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.5.3 Market by Geography
13.6 Others
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.6.3 Market by Geography
14 Application
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Diagnosis
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Market by Geography
14.4 Preclinical Testings
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Market by Geography
15 Indication
15.1 Market Snapshot & Growth Engine
15.2 Market Overview
15.3 Viral Diseases
15.3.1 Market Overview
15.3.2 Market Size & Forecast
15.3.3 Market by Geography
15.4 Non-Viral Disease
15.4.1 Market Overview
15.4.2 Market Size & Forecast
15.4.3 Market by Geography
16 End-Users
16.1 Market Snapshot & Growth Engine
16.2 Market Overview
16.3 Diagnostic Labs
16.3.1 Market Overview
16.3.2 Market Size & Forecast
16.3.3 Market by Geography
16.4 Hospitals and Clinics
16.4.1 Market Overview
16.4.2 Market Size & Forecast
16.4.3 Market by Geography
16.5 Others
16.5.1 Market Overview
16.5.2 Market Size & Forecast
16.5.3 Market by Geography
17 Geography
17.1 Market Snapshot & Growth Engine
17.2 Geographic Overview
18 North America
18.1 Market Overview
18.2 Market Size & Forecast
18.3 Product
18.3.1 Market Size & Forecast
18.4 Application
18.4.1 Market Size & Forecast
18.5 Indication
18.5.1 Market Size & Forecast
18.6 End-Users
18.6.1 Market Size & Forecast
18.7 Key Countries
18.7.1 Us: Market Size & Forecast
18.7.2 Canada: Market Size & Forecast
19 Europe
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Product
19.3.1 Market Size & Forecast
19.4 Application
19.4.1 Market Size & Forecast
19.5 Indication
19.5.1 Market Size & Forecast
19.6 End-Users
19.6.1 Market Size & Forecast
19.7 Key Countries
19.7.1 Uk: Market Size & Forecast
19.7.2 Italy: Market Size & Forecast
19.7.3 France: Market Size & Forecast
19.7.4 Germany: Market Size & Forecast
19.7.5 Spain: Market Size & Forecast
20 Apac
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Product
20.3.1 Market Size & Forecast
20.4 Application
20.4.1 Market Size & Forecast
20.5 Indication
20.5.1 Market Size & Forecast
20.6 End-Users
20.6.1 Market Size & Forecast
20.7 Key Countries
20.7.1 China: Market Size & Forecast
20.7.2 Japan: Market Size & Forecast
20.7.3 India: Market Size & Forecast
20.7.4 Australia: Market Size & Forecast
20.7.5 South Korea: Market Size & Forecast
21 Latin America
21.1 Market Overview
21.2 Market Size & Forecast
21.3 Product
21.3.1 Market Size & Forecast
21.4 Application
21.4.1 Market Size & Forecast
21.5 Indication
21.5.1 Market Size & Forecast
21.6 End-Users
21.6.1 Market Size & Forecast
21.7 Key Countries
21.7.1 Brazil: Market Size & Forecast
21.7.2 Mexico: Market Size & Forecast
21.7.3 Argentina: Market Size & Forecast
22 Middle East Africa
22.1 Market Overview
22.2 Market Size & Forecast
22.3 Product
22.3.1 Market Size & Forecast
22.4 Application
22.4.1 Market Size & Forecast
22.5 Indication
22.5.1 Market Size & Forecast
22.6 End-Users
22.6.1 Market Size & Forecast
22.7 Key Countries
22.7.1 Turkey: Market Size & Forecast
22.7.2 Saudi Arabia: Market Size & Forecast
22.7.3 South Africa: Market Size & Forecast
23 Competitive Landscape
23.1 Competition Overview
23.2 Market Share Analysis
23.2.1 Bd
23.2.2 Hardy Diagnostics
23.2.3 Himedia Laboratories
23.2.4 Laboratory Corporation of America
23.2.5 Puritan Medical Products
23.2.6 Thermo Fisher Scientific
23.2.7 Vircell
24 Key Company Profiles
24.1 Bd
24.1.1 Business Overview
24.1.2 Product Offerings
24.1.3 Key Strategies
24.1.4 Key Strengths
24.1.5 Key Opportunities
24.2 Hardy Diagnostics
24.2.1 Business Overview
24.2.2 Product Offerings
24.2.3 Key Strategies
24.2.4 Key Strengths
24.2.5 Key Opportunities
24.3 Himedia Laboratories
24.3.1 Business Overview
24.3.2 Product Offerings
24.3.3 Key Strategies
24.3.4 Key Strengths
24.3.5 Key Opportunities
24.4 Laboratory Corporation of America
24.4.1 Business Overview
24.4.2 Product Offerings
24.4.3 Key Strategies
24.4.4 Key Strengths
24.4.5 Key Opportunities
24.5 Puritan Medical Products
24.5.1 Business Overview
24.5.2 Product Offerings
24.5.3 Key Strategies
24.5.4 Key Strengths
24.5.5 Key Opportunities
24.6 Thermo Fisher Scientific
24.6.1 Business Overview
24.6.2 Thermo Fisher Scientific in Transport Media Market
24.6.3 Product Offerings
24.6.4 Key Strategies
24.6.5 Key Strengths
24.6.6 Key Opportunities
24.7 Vircell
24.7.1 Business Overview
24.7.2 Product Offerings
24.7.3 Key Strategies
24.7.4 Key Strengths
24.7.5 Key Opportunities
25 Other Prominent Vendors
25.1 Ab Medical
25.1.1 Business Overview
25.1.2 Product Offerings
25.2 Alpha-Tec Systems
25.2.1 Business Overview
25.2.2 Product Offerings
25.3 Accugene Usa
25.3.1 Business Overview
25.3.2 Product Offerings
25.4 Apical Scientific
25.4.1 Business Overview
25.4.2 Product Offerings
25.5 Azooka Labs
25.5.1 Business Overview
25.5.2 Product Offerings
25.6 Biomed Diagnostics
25.6.1 Business Overview
25.6.2 Product Offerings
25.7 Bioboavista
25.7.1 Business Overview
25.7.2 Product Offerings
25.8 Biogenex
25.8.1 Business Overview
25.8.2 Product Offerings
25.9 Biologix Group
25.9.1 Business Overview
25.9.2 Product Offerings
25.10 Biocomma
25.10.1 Business Overview
25.10.2 Product Offerings
25.11 Charm Sciences
25.11.1 Business Overview
25.11.2 Product Offerings
25.12 Creative Life Sciences Co. Ltd.
25.12.1 Business Overview
25.12.2 Product Offerings
25.13 Citotest Labware Manufacturing
25.13.1 Business Overview
25.13.2 Product Offerings
25.14 Cpt Medical
25.14.1 Business Overview
25.14.2 Product Offerings
25.15 Copan Diagnostics
25.15.1 Business Overview
25.15.2 Product Offerings
25.16 Diasorin Molecular
25.16.1 Business Overview
25.16.2 Product Offerings
25.17 Efk Diagnostics Holding
25.17.1 Business Overview
25.17.2 Product Offerings
25.18 Ensol Biosciences
25.18.1 Business Overview
25.18.2 Product Offerings
25.19 General Biologics
25.19.1 Business Overview
25.19.2 Product Offerings
25.20 Gentueri
25.20.1 Business Overview
25.20.2 Product Offerings
25.21 Hang Chang Medic
25.21.1 Business Overview
25.21.2 Product Offerings
25.22 Hebei Chaoran Medical Instruments
25.22.1 Business Overview
25.22.2 Product Offerings
25.23 Innolyzer Labs
25.23.1 Business Overview
25.23.2 Product Offerings
25.24 Ksl Diagnostics
25.24.1 Business Overview
25.24.2 Product Offerings
25.25 Lucence Health
25.25.1 Business Overview
25.25.2 Product Offerings
25.26 Launchworks
25.26.1 Business Overview
25.26.2 Product Offerings
25.27 Liofilchem
25.27.1 Business Overview
25.27.2 Product Offerings
25.28 Medical Wire & Equipment
25.28.1 Business Overview
25.28.2 Product Offerings
25.29 Miraclean Technology
25.29.1 Business Overview
25.29.2 Product Offerings
25.30 Metadesign Solutions
25.30.1 Business Overview
25.30.2 Product Offerings
25.31 Quidel Corporation
25.31.1 Business Overview
25.31.2 Product Offerings
25.32 Trinity Biotech
25.32.1 Business Overview
25.32.2 Product Offerings
25.33 Manila Healthtek
25.33.1 Business Overview
25.33.2 Product Offerings
25.34 Mattek
25.34.1 Business Overview
25.34.2 Product Offerings
25.35 Nodford International
25.35.1 Business Overview
25.35.2 Product Offerings
25.36 Starplex Scientific
25.36.1 Business Overview
25.36.2 Product Offerings
25.37 Sansure Biotech
25.37.1 Business Overview
25.37.2 Product Offerings
25.38 Sisco Research Laboratories
25.38.1 Business Overview
25.38.2 Product Offerings
25.39 Teknova
25.39.1 Business Overview
25.39.2 Product Offerings
25.40 Titan Biotech
25.40.1 Business Overview
25.40.2 Product Offerings
25.41 Vegas Biotech
25.41.1 Business Overview
25.41.2 Product Offerings
25.42 Yocon Biology Technology Company
25.42.1 Business Overview
25.42.2 Product Offerings
25.43 Zybio
25.43.1 Business Overview
25.43.2 Product Offerings
26 Report Summary
26.1 Key Takeaways
26.2 Strategic Recommendations
27 Quantitative Summary
27.1 Market by Geography
27.2 Market by Product
27.3 Market by Application
27.4 Market by Indication
27.5 Market by End-Users
27.6 Product: Market by Geography
27.6.1 Viral Transport Media: Market by Geography
27.6.2 Universal Transport Media: Market by Geography
27.6.3 Molecular Transport Media: Market by Geography
27.6.4 Other Transport Media: Market by Geography
27.7 Application: Market by Geography
27.7.1 Diagnosis: Market by Geography
27.7.2 Pre-Clinical Testing: Market by Geography
27.8 Indication: Market by Geography
27.8.1 Viral Disease: Market by Geography
27.8.2 Non-Viral Disease: Market by Geography
27.9 End-Users: Market by Geography
27.9.1 Diagnostic Labs: Market by Geography
27.9.2 Hospitals & Clinics: Market by Geography
27.9.3 Other End-Users: Market by Geography
28 Appendix
28.1 Abbreviations
Companies Mentioned
- BD
- Hardy Diagnostics
- HiMedia Laboratories
- Laboratory Corporation of America
- Puritan Medica Products
- Thermo Fisher Scientific
- Vircell
- AB Medical
- Alpha-Tec Systems
- AccuGene USA
- Apical Scientific
- Azooka Labs
- Biomed Diagnostics
- bioBoaVista
- BioGenex
- BIOLOGIX Group
- BIOCOMMA
- Charm Sciences
- Creative Life Sciences
- Citotest Labware Manufacturing
- CPT Medical
- COPAN Diagnostics
- DiaSorin Molecular
- EKF Diagnostics Holding
- Ensol Biosciences
- General Biologics
- Gentueri
- Han Chang Medic
- Hebei Chaoran Medical Instruments
- Innolyzer Labs
- KSL Diagnostics
- Lucence Health
- LaunchWorks
- Liofilchem
- Medical Wire & Equipment
- Miraclean Technology
- MetaDesign Solutions
- Quidel Corporation
- Trinity Biotech
- Manila HealthTek
- MATTEK
- Nodford International
- Starplex Scientific
- Sansure Biotech
- Sisco Research Laboratories
- Teknova
- Titan Biotech
- Vegas Biotech
- Yocon Biology Technology Company
- Zybio
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
